Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which is roughly the size of a quarter and weighs less than 2 grams, could help ...